Next Article in Journal
Antiproliferative and Antioxidant Properties of Anthocyanin Rich Extracts from Blueberry and Blackcurrant Juice
Next Article in Special Issue
The Regulation and Function of miR-21-FOXO3a-miR-34b/c Signaling in Breast Cancer
Previous Article in Journal
Gentamicin Arrests Cancer Cell Growth: The Intriguing Involvement of Nuclear Sphingomyelin Metabolism
Previous Article in Special Issue
HCN Channels—Modulators of Cardiac and Neuronal Excitability
Open AccessReview

Cyclic Nucleotide Signalling in Kidney Fibrosis

Pharmacology and Toxicology, University Regensburg, Regensburg 93053, Germany
Author to whom correspondence should be addressed.
Academic Editor: Ritva Tikkanen
Int. J. Mol. Sci. 2015, 16(2), 2320-2351;
Received: 24 October 2014 / Revised: 14 November 2014 / Accepted: 14 January 2015 / Published: 22 January 2015
(This article belongs to the Special Issue Signalling Molecules and Signal Transduction in Cells 2014)
Kidney fibrosis is an important factor for the progression of kidney diseases, e.g., diabetes mellitus induced kidney failure, glomerulosclerosis and nephritis resulting in chronic kidney disease or end-stage renal disease. Cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) were implicated to suppress several of the above mentioned renal diseases. In this review article, identified effects and mechanisms of cGMP and cAMP regarding renal fibrosis are summarized. These mechanisms include several signalling pathways of nitric oxide/ANP/guanylyl cyclases/cGMP-dependent protein kinase and cAMP/Epac/adenylyl cyclases/cAMP-dependent protein kinase. Furthermore, diverse possible drugs activating these pathways are discussed. From these diverse mechanisms it is expected that new pharmacological treatments will evolve for the therapy or even prevention of kidney failure. View Full-Text
Keywords: signalling; cyclic nucleotides; cyclic guanosine monophosphate; cyclic adenosine monophosphate; kidney fibrosis signalling; cyclic nucleotides; cyclic guanosine monophosphate; cyclic adenosine monophosphate; kidney fibrosis
Show Figures

Figure 1

MDPI and ACS Style

Schinner, E.; Wetzl, V.; Schlossmann, J. Cyclic Nucleotide Signalling in Kidney Fibrosis. Int. J. Mol. Sci. 2015, 16, 2320-2351.

Show more citation formats Show less citations formats

Article Access Map

Only visits after 24 November 2015 are recorded.
Back to TopTop